Skip to content

Clinical trials

Observational Multiple Sclerosis, Chronic Progressive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Phase: Observational Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20122
20131
20142
20154
20161
20171
20184
20192
20202
20215
20225
20234
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting5
Unknown status4
Enrolling by invitation2
Not yet recruiting1
Suspended1
Terminated1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Bayer3
Novartis3
Danish Research Centre for Magnetic Resonance2
State University of New York at Buffalo2
University Hospital, Basel, Switzerland2
Cedars-Sinai Medical Center1
Duke University1
Friedemann Paul1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive46
Multiple Sclerosis, Relapsing-Remitting27
Multiple Sclerosis26
Disease Progression3
Autoimmune Diseases2
Fatigue Syndrome, Chronic2
Nervous System Diseases2
Acne Vulgaris1
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1

Trials

Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.